Spyre Therapeutics, Inc. (GETTEX:3920) Cap table
Cap table
Built by 6ix from Spyre Therapeutics, Inc.’s releases · as of Nov 3, 2026
- Common shares
- 94,969,184
- Fully diluted
- 94,983,517
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 94,969,184 | Oct 27, 2026 |
| Options and RSUs | 14,333 | Nov 2, 2026 |
Warrants and options
| Lot |
|---|
| Stock options · US$95.51 · expire about Nov 2036 |
| RSUs · expiry not stated |
Share count over time
| Count | Shares |
|---|---|
| Oct 27, 2026 | 94,969,184 |